IPSC | Century Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.0450 - 1.1200
52 Week Range	0.9800 - 5.51
Beta	1.88
Implied Volatility	392.89%
IV Rank	98.57%
Day's Volume	794,496
Average Volume	533,877
Shares Outstanding	85,029,000
Market Cap	93,531,900
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-06-18

Valuation
Profitability
Growth
Health
P/E Ratio	-0.60
Forward P/E Ratio	N/A
EPS	-1.83
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	152
Country	USA
Website	IPSC

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.

IPSC's peers: ADCT, ALLO, ALXO, ARVN, AVTX, BCAB, PMCB, CCCC, CDXC, CDXS, CGEM, CLGN, CLNN, CNTA, CSBR, ENLV, ENTA, ERAS, EWTX, FATE, FDMT, FHTX, GBIO, HCWB, IOBT, IPA, IPHA, MLYS, PASG, FIXX, STOK, NGM, KROS, GLUE, KZR, NKTX, THRX, LIFE, RLAY, BPMC, KYMR, LYEL, MDXG, MGNX, MTEM, MTNB, NAUT, PSTX, RLMD, RLYB, SLDB, STTK, TYRA, VCEL, VERV, HLVX, PEPG, PRME, OABI, MLEC

*Chart delayed

Analyzing fundamentals for IPSC we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see IPSC Fundamentals page.

Watching at IPSC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on IPSC Technicals page.